Corporate ActionMay 8, 2026, 10:53 AM
Cytokinetics Closes $805M Public Offering of Common Stock
AI Summary
Cytokinetics, Incorporated announced the closing of its underwritten public offering of common stock, generating approximately $805 million in gross proceeds. The company sold a total of 11,338,028 shares, including the full exercise of the underwriters' option, at a price of $71.00 per share. This capital raise was conducted pursuant to a shelf registration statement.
Key Highlights
- Cytokinetics closed an underwritten public offering of common stock.
- Gross proceeds to Cytokinetics were approximately $805 million.
- The company sold 11,338,028 shares of common stock.
- The shares were priced at $71.00 per share.
- Underwriters fully exercised their option to purchase 1,478,873 additional shares.